These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12793902)

  • 1. Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype.
    Núñez-Villar MJ; Martínez-Arribas F; Pollán M; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Breast Cancer Res; 2003; 5(3):R65-70. PubMed ID: 12793902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
    Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
    J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors.
    Roncella S; Ferro P; Bacigalupo B; Dessanti P; Giannico A; Gorji N; Moroni M; Tozzini S; Pensa F; Gianquinto D; Fais F; Pronzato P; Fedeli F
    J Exp Clin Cancer Res; 2006 Mar; 25(1):65-72. PubMed ID: 16761620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer.
    Agudo D; Gómez-Esquer F; Martínez-Arribas F; Núñez-Villar MJ; Pollán M; Schneider J
    Int J Cancer; 2004 May; 109(5):717-20. PubMed ID: 14999780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer.
    Ballestrero A; Garuti A; Bertolotto M; Rocco I; Boy D; Nencioni A; Ottonello L; Patrone F
    Br J Cancer; 2005 May; 92(10):1948-52. PubMed ID: 15841077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammaglobin, a potential marker of breast cancer nodal metastasis.
    Leygue E; Snell L; Dotzlaw H; Hole K; Troup S; Hiller-Hitchcock T; Murphy LC; Watson PH
    J Pathol; 1999 Sep; 189(1):28-33. PubMed ID: 10451484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.
    Ouellette RJ; Richard D; Maïcas E
    Am J Clin Pathol; 2004 May; 121(5):637-43. PubMed ID: 15151203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
    Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
    Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammaglobin expression in primary, metastatic, and occult breast cancer.
    Watson MA; Dintzis S; Darrow CM; Voss LE; DiPersio J; Jensen R; Fleming TP
    Cancer Res; 1999 Jul; 59(13):3028-31. PubMed ID: 10397237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation measurement in breast cancer by two different methods.
    Martínez-Arribas F; Martín-Garabato E; Lafuente P; Tejerina A; Lucas R; Sánchez J; Schneider J
    Anticancer Res; 2006; 26(1A):199-202. PubMed ID: 16475699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
    Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of micrometastases in lymph nodes from patients with breast cancer.
    Branagan G; Hughes D; Jeffrey M; Crane-Robinson C; Perry PM
    Br J Surg; 2002 Jan; 89(1):86-9. PubMed ID: 11851670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the histological size of the sentinel lymph node metastases using RT-PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer.
    Veys I; Majjaj S; Salgado R; Noterman D; Schobbens JC; Manouach F; Bourgeois P; Nogaret JM; Larsimont D; Durbecq V
    Breast Cancer Res Treat; 2010 Dec; 124(3):599-605. PubMed ID: 19779817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation.
    Sjödin A; Ljuslinder I; Henriksson R; Hedman H
    Anticancer Res; 2008; 28(3A):1493-8. PubMed ID: 18630503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients.
    Viale G; Dell'Orto P; Biasi MO; Stufano V; De Brito Lima LN; Paganelli G; Maisonneuve P; Vargo JM; Green G; Cao W; Swijter A; Mazzarol G
    Ann Surg; 2008 Jan; 247(1):136-42. PubMed ID: 18156933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients.
    Li G; Zhang J; Jin K; He K; Wang H; Lu H; Teng L
    Biomark Med; 2011 Apr; 5(2):249-60. PubMed ID: 21473729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: association with clinical prognostic factors.
    Ferro P; Franceschini MC; Bacigalupo B; Dessanti P; Falco E; Fontana V; Gianquinto D; Pistillo MP; Fedeli F; Roncella S
    Anticancer Res; 2010 Jun; 30(6):2377-82. PubMed ID: 20651396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.